Kura Oncology, Inc. (KURA)
8.805
+0.24
(+2.86%)
USD |
NASDAQ |
Jun 09, 16:00
8.805
0.00 (0.00%)
After-Hours: 19:37
Kura Oncology Total Liabilities (Quarterly) : 544.67M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 55.03M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Exelixis, Inc. | 657.84M |
| Gilead Sciences, Inc. | 32.85B |
| Capricor Therapeutics, Inc. | 47.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 652.55M |
| Shareholders Equity (Quarterly) | 107.88M |
| Debt to Equity Ratio | 0.225 |
| Current Ratio | 6.146 |
| Net Debt Paydown Yield | -0.21% |